SEARCH RESULTS

1 RESULT

Hussein Yassine on Biogen/Eisai Halt Phase 3 Aducanumab Trials

COMMENT The results of the recent aducanumab trial is a major disappointment to the field, but it is not surprising. Moving forward, we can learn for the cardiovascular field. Raising HDL cholesterol (HDL-C) did not translate into cardiovascular benefit in ...

Current Filters

  • TYPE: Comment x
  • Commentator: Yassine, Hussein x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE